[ad_1]
The Bahrain News Agency (BNA) said the National Authority for the Regulation of Health Professions and Services has approved the emergency use of the vaccine, to be the fifth vaccine authorized in the Kingdom for use in emergency groups most at risk from Coronavirus, including the elderly, people with chronic diseases and other groups identified by the Department of Health with the aim of providing anti-virus vaccines.
The CEO of the National Health Regulatory Authority, Maryam Athbi Al-Jalahma, said a thorough review of all documents submitted by the company containing the results of the vaccination study had been conducted. Information provided by the company on the results of vaccine studies conducted in several countries and the results of immunity.
It should be noted that the “Janssen” vaccine is administered in a single dose and offers strong protection against severe infection by “Covid 19”.
Thus, Bahrain will be the first country in the world to allow widespread use of the “Johnson & Johnson” vaccine, and in total the company aims to produce around one billion doses by the end of the year.
[ad_2]
Source link
